Bioavailability Study of Five Tablet Formulations of Dabigatran Etexilate Compared to Commercial Capsule Formulation in Healthy Male Subjects
Clinical trial NCT02710630 · COMPLETED
Trial details
- NCT number
- NCT02710630
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-22
- Primary completion
- 2016-05-11
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.